| 2013-10 | Impact Of CT-P13 and Originator Infliximab Treatment On Quality Of Life Derived From The Health Assessment Questionnaire (HAQ) and Short-Form 36 (SF-36) From a Randomized, Double-Blind Trial In Patients With Active RA | 유대현 |
| 2017-07 | Impact of early diagnosis on functional disability in rheumatoid arthritis | 유대현 |
| 2017-10 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis | 유대현 |
| 2013-06 | IMPACTS OF IMMEDIATE CHANGES IN DMARDS ON OUTCOMES IN RHEUMATOID ARTHRITIS WITH MODERATE-TO-SEVERE ACTIVITY | 유대현 |
| 2016-01 | The importance of assessment and management of morning stiffness in Asian patients with rheumatoid arthritis: Recommendations from an expert panel | 유대현 |
| 2016-02 | Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus | 유대현 |
| 2019-02 | Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study | 유대현 |
| 2016-09 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study | 유대현 |
| 2020-06 | An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea | 유대현 |
| 2020-05 | Increased risk of malignancy in patients aged over 50 with idiopathic inflammatory myositis compared to patients with osteoarthritis of the knee | 유대현 |
| 2013-10 | Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy? | 유대현 |
| 2018-09 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy | 유대현 |
| 2012-06 | Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South Korea | 유대현 |
| 2019-02 | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 유대현 |
| 2015-04 | Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients | 유대현 |
| 2016-04 | Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data | 유대현 |
| 2013-06 | MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still's disease | 유대현 |
| 2011-10 | Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-kappa B and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis | 유대현 |
| 2013-06 | METHOTREXATE DOSE AND OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS | 유대현 |
| 2013-05 | Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease | 유대현 |
| 2017-03 | A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis | 유대현 |
| 2012-09 | Natural Killer T Cell Deficiency in Active Adult-Onset Still's Disease Correlation of Deficiency of Natural Killer T Cells With Dysfunction of Natural Killer Cells | 유대현 |
| 2011-06 | Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity | 유대현 |
| 2018-05 | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 유대현 |
| 2020-11 | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 유대현 |
| 2013-06 | A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY | 유대현 |
| 2016-04 | A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study | 유대현 |
| 2013-06 | PILOT TRIAL OF TOCILIZUMAB FOR REFRACTORY PATIENTS WITH ADULT ONSET STILL'S DISEASE | 유대현 |
| 2013-06 | PREDICTOR OF RENAL SURVIVAL IN LUPUS NEPHRITIS IN KOREA | 유대현 |
| 2016-09 | Prevalence and possible causes of hypouricemia at a tertiary care hospital | 유대현 |
